Trilogy Capital Inc. Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Trilogy Capital Inc. acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 471 shares of the healthcare conglomerate’s stock, valued at approximately $233,000.

Other institutional investors have also modified their holdings of the company. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC lifted its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $31,000. LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on UNH shares. Piper Sandler raised their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Morgan Stanley reduced their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Royal Bank of Canada cut their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $579.74.

Read Our Latest Report on UnitedHealth Group

UnitedHealth Group Stock Performance

UNH traded up $22.82 on Friday, reaching $509.26. 22,734,197 shares of the stock were exchanged, compared to its average volume of 3,685,941. The company’s 50-day moving average price is $498.34 and its 200 day moving average price is $501.96. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $468.72 billion, a PE ratio of 31.13, a PEG ratio of 1.48 and a beta of 0.58.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the previous year, the firm posted $6.26 EPS. The firm’s revenue was up 8.6% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.